122 related articles for article (PubMed ID: 1898521)
1. Cultured human bladder tumors for pharmacodynamic studies.
Schmittgen TD; Au JL; Wientjes MG; Badalament RA; Drago JR
J Urol; 1991 Jan; 145(1):203-7. PubMed ID: 1898521
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of mitomycin C in cultured human bladder tumors.
Schmittgen TD; Wientjes MG; Badalament RA; Au JL
Cancer Res; 1991 Aug; 51(15):3849-56. PubMed ID: 1906778
[TBL] [Abstract][Full Text] [Related]
3. Regional heterogeneity and pharmacodynamics in human solid tumor histoculture.
Weaver JR; Wientjes MG; Au JL
Cancer Chemother Pharmacol; 1999; 44(4):335-42. PubMed ID: 10447582
[TBL] [Abstract][Full Text] [Related]
4. [Chemosensitivity test on superficial urinary bladder cancer using the dye exclusion assay--model of intravesical chemotherapy].
Koseki K; Irisawa C; Shiraiwa Y
Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):268-73. PubMed ID: 1904118
[TBL] [Abstract][Full Text] [Related]
5. Correlation of human bladder tumor histoculture proliferation and sensitivity to mitomycin C with tumor pathobiology.
Schmittgen TD; Weaver JM; Badalament RA; Wientjes MG; Klein EA; Young DC; Au JL
J Urol; 1994 Nov; 152(5 Pt 1):1632-6. PubMed ID: 7933219
[TBL] [Abstract][Full Text] [Related]
6. [Intracavitary instillation for bladder tumor with antitumor agent. 5th Report: Difference of the action of mitomycin C on normal bladder and tumor of the bladder (experimental and clinical study)].
Ogawa H; Hiraoka Y; Kawai H
Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):596-607. PubMed ID: 6413739
[No Abstract] [Full Text] [Related]
7. Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures.
Yen WC; Schmittgen T; Au JL
Pharm Res; 1996 Dec; 13(12):1887-91. PubMed ID: 8987090
[TBL] [Abstract][Full Text] [Related]
8. In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer.
Seraphim LA; Perrapato SD; Slocum HK; Rustum YM; Huben RP
J Urol; 1991 Mar; 145(3):613-7. PubMed ID: 1900087
[TBL] [Abstract][Full Text] [Related]
9. In vitro chemosensitivity of human bladder cancer.
Weisenthal LM; Lalude AO; Miller JB
Cancer; 1983 Apr; 51(8):1490-6. PubMed ID: 6186358
[TBL] [Abstract][Full Text] [Related]
10. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). 3].
Ogawa H
Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):728-45. PubMed ID: 5388928
[No Abstract] [Full Text] [Related]
11. Pharmacodynamic evaluation of mitomycin C analog BMS-181174 for potential use in intravesical bladder cancer therapy.
Yen WC; Au JL
Pharm Res; 1997 Feb; 14(2):241-5. PubMed ID: 9090717
[No Abstract] [Full Text] [Related]
12. Severely contracted bladder following intravesical mitomycin C therapy.
Wajsman Z; McGill W; Englander L; Huben RP; Pontes JE
J Urol; 1983 Aug; 130(2):340-1. PubMed ID: 6410085
[TBL] [Abstract][Full Text] [Related]
13. Distilled water versus chemotherapeutic agents for transitional bladder carcinoma.
Levin DR; Moskovitz B
Eur Urol; 1986; 12(6):418-21. PubMed ID: 3102241
[TBL] [Abstract][Full Text] [Related]
14. The effect of verapamil on a multi-drug resistant bladder carcinoma cell line and its potential as an intravesical chemotherapeutic agent.
Long JP; Prout GR; Wong YK; Lin CW
J Urol; 1990 May; 143(5):1053-6. PubMed ID: 2329596
[TBL] [Abstract][Full Text] [Related]
15. Mitomycin C in the treatment of metastatic transitional cell carcinoma of urinary bladder.
Early K; Elias EG; Mittelman A; Albert D; Murphy GP
Cancer; 1973 May; 31(5):1150-3. PubMed ID: 4705151
[No Abstract] [Full Text] [Related]
16. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). IV].
Ogawa H
Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):746-55. PubMed ID: 5388929
[No Abstract] [Full Text] [Related]
17. [Chemosensitivity test for gastric cancer by in vitro MTT assay].
Ohyama S; Yonemura Y; Kinoshita K; Ninomiya I; Tugawa K; Kimura H; Miyazaki I; Tanaka M; Endo Y; Sasaki T
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1593-7. PubMed ID: 1908213
[TBL] [Abstract][Full Text] [Related]
18. Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
Groos E; Masters JR
J Urol; 1986 Aug; 136(2):399-402. PubMed ID: 3090275
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of an in vitro chemosensitivity test, the Histoculture Drug Response Assay, to urological cancers: wide distribution of inhibition rates in bladder cancer and renal cell cancer.
Hirano Y; Ushiyama T; Suzuki K; Fujita K
Urol Res; 1999 Dec; 27(6):483-8. PubMed ID: 10651138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
